Phase III data on novel, lanthanum carbonate phosphate binder presented at conference

被引：0

|

作者：

不详

机构：

来源：

DIALYSIS & TRANSPLANTATION | 2003年 / 32卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

引用

收藏

页码：312 / 312

页数：1

相关论文

共 50 条

[31] Lanthanum Carbonate Provides Control of Phosphorus Levels in Patients New to Phosphate Binder Therapy and Patients Changed From Other Phosphate Binders
Noto, Linda
JOURNAL OF RENAL NUTRITION, 2011, 21 (03) : 277 - 282
[32] Analysis of liver function and hepatobiliary adverse event data from 2000 dialysis patients participating in clinical trials on the new phosphate binder, lanthanum carbonate
Hutchison, A
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V93 - V93
[33] Restoration of Parathyroid Function After Change of Phosphate Binder From Calcium Carbonate to Lanthanum Carbonate in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone
Inaba, Masaaki
Okuno, Senji
Nagayama, Harumi
Yamada, Shinsuke
Ishimura, Eiji
Imanishi, Yasuo
Shoji, Shigeichi
JOURNAL OF RENAL NUTRITION, 2015, 25 (02) : 242 - 246
[34] Lanthanum carbonate vs standard phosphate binder therapy: Evolution of renal osteodystrophy over 1 and 2 years of treatment
Malluche, Hartmut H.
Pratt, Raymond D.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A58 - A58
[35] The pharmacology of lanthanum carbonate (Fosrenol®):: A new non-aluminum-, non-calcium-based phosphate binder.
Damment, SJP
Webster, I
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 204A - 205A
[36] LANTHANUM CARBONATE DELAYS THE PROGRESSION OF CORONARY ARTERY CALCIFICATION COMPARED WITH CALCIUM-BASED PHOSPHATE BINDER IN PATIENTS ON HEMODIALYSIS
Ohtake, Takayasu
Ohtake, Takayasu
Furuya, Rei
Iwagami, Masao
Tsutsumi, Daimu
Mochida, Yasuhiro
Ishioka, Kunihiro
Oka, Machiko
Maesato, Kyoko
Moriya, Hidekazu
Hidaka, Sumi
Kobayashi, Shuzo
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 229 - 229
[37] SEPARATION OF LANTHANUM(III) AND NEODYMIUM(III) BY EXTRACTION WITH TRIBUTYL-PHOSPHATE IN THE PRESENCE OF A SOLID-PHASE
KOROTKEVICH, IB
KOLESNIKOV, AA
BOMSHTEIN, VE
SHIKHALEEVA, NN
SOVIET RADIOCHEMISTRY, 1987, 29 (03): : 311 - 316
[38] The pharmacokinetics and tissue distribution of lanthanum carbonate (Fosrenol®), a new non-aluminum, non-calcium phosphate binder.
Damment, SJP
Gill, M
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 204A - 204A
[39] Efficacy and safety of long-term treatment with lanthanum carbonate - A novel phosphate-binding agent
Finn, W
Joy, M
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A18 - A18
[40] GelTex Pharmaceuticals reports positive preliminary Phase III clinical results for RenaGel phosphate binder
不详
DIALYSIS & TRANSPLANTATION, 1997, 26 (03) : 126 - 127

← 1 2 3 4 5 →